Snapshot from Jul 19, 2026 at 14:14 UTC. For live data and tracking: View Live
Person

Rishabh Gupta

Tracked across 1 events · 6 articles · First seen Apr 02, 2026 · Last active Jul 15, 2026

Sentiment
-30
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 -30
Regulatory
Unicycive Therapeutics received a Complete Response Letter (CRL) from the FDA regarding its resubmitted New Drug Application for oxylanthanum carbonate (OLC), a treatment for hyperphosphatemia in chronic kidney disease patients on dialysis. The CRL is…
Impact: As CEO, Rishabh Gupta expressed confidence in OLC's efficacy and safety, and optimism about resolving the manufacturing issue and resubmitting the NDA.
Jun 30, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Rishabh Gupta live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.